Breaking Pope Francis to Visit Argentina Amid Economic Hardship Ohio State Coach Ryan Day Addresses Offensive Line Concerns Ahead of 2026 Season Georgia Father Seeks New Trial in Son’s School Shooting Case Former Federal Prosecutor Sues Justice Department Over Termination, Citing First Amendment Rights Judge Pauses Order for Trump’s Financial Records in BBC Defamation Case

Friday August 7, 2026

Reporter

Replimune, Inc.

2Articles Published

4Communities Covered

Published Articles

Press Release

Replimune Announces FDA Accelerated Approval of TUDRIQEVTM in Combination with Nivolumab for Unresectable Advanced Cutaneous Melanoma After Progression on an anti-PD-1 Based Regimen

Aug 6

Press Release

Replimune Announces Favorable Outcome of FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma

Jul 30